Matches in SemOpenAlex for { <https://semopenalex.org/work/W3175679928> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W3175679928 endingPage "e831" @default.
- W3175679928 startingPage "e820" @default.
- W3175679928 abstract "Multiple treatment options in first-line chronic lymphocytic leukemia (CLL) pose a challenge in identifying the best treatment. We performed novel network meta-analyses (NMA; 8 trials, 11 treatments) on the Kaplan-Meier curves to compare treatments for fludarabine-ineligible patients on progression-free survival (PFS), time-to-next-treatment (TTNT) and overall survival (OS).Using the Guyot method of enhanced secondary analysis of digitized survival data and applying the fixed lognormal distribution model, we extracted the survival proportions and hazard ratios (HR) over 60 months of follow-up, including PFS comparisons by unmutated/mutated IGHV and del 17p.Acalabrutinib-plus-obinutuzumab was associated with higher 5-year PFS proportions than ibrutinib (HR = 0.42, 95% CrI = 0.25-0.63) but not acalabrutinib, ibrutinib-plus-obinutuzumab, ibrutinib-plus-rituximab or venetoclax-plus-obinutuzumab. In patients with un-mutated (but not with mutated) IGHV higher PFS proportions and favorable HRs were observed for acalabrutinib, acalabrutinib-plus-obinutuzumab, and ibrutinib-plus-obinutuzumab relative to ibrutinib; and targeted therapies were superior over chemoimmunotherapies in patients with del 17p. Targeted therapies containing ibrutinib or acalabrutinib regimens were associated with superior TTNT over venetoclax-plus-obinutuzumab and all chemoimmunotherapies. OS NMA generally found no difference between therapies except for some chemoimmunotherapies.Overall, only acalabrutinib-plus-obinutuzumab was associated with superior 5-year PFS gains over ibrutinib, which in turn was similar or superior in PFS benefit over other targeted therapies. Acalabrutinib and ibrutinib with obinutuzumab and acalabrutinib monotherapy were associated with greater 5-year TTNT benefits. Despite marked 5-year OS for many regimens, a differential 5-year OS benefit could not be ascertained." @default.
- W3175679928 created "2021-07-05" @default.
- W3175679928 creator A5022744383 @default.
- W3175679928 creator A5031658471 @default.
- W3175679928 creator A5031828516 @default.
- W3175679928 creator A5049387929 @default.
- W3175679928 creator A5073861459 @default.
- W3175679928 creator A5085732144 @default.
- W3175679928 date "2021-11-01" @default.
- W3175679928 modified "2023-09-30" @default.
- W3175679928 title "Comparative Efficacy of First-Line Treatments of Chronic Lymphocytic Leukemia: Network Meta-Analyses of Survival Curves" @default.
- W3175679928 cites W1910740057 @default.
- W3175679928 cites W1982967337 @default.
- W3175679928 cites W2005501262 @default.
- W3175679928 cites W2038107959 @default.
- W3175679928 cites W2059573268 @default.
- W3175679928 cites W2099145932 @default.
- W3175679928 cites W2116835043 @default.
- W3175679928 cites W2120319857 @default.
- W3175679928 cites W2124847703 @default.
- W3175679928 cites W2135369095 @default.
- W3175679928 cites W2233614027 @default.
- W3175679928 cites W2409844048 @default.
- W3175679928 cites W2461753455 @default.
- W3175679928 cites W2553911513 @default.
- W3175679928 cites W2557337948 @default.
- W3175679928 cites W2725087275 @default.
- W3175679928 cites W2766509541 @default.
- W3175679928 cites W2774223142 @default.
- W3175679928 cites W2788803761 @default.
- W3175679928 cites W2791345134 @default.
- W3175679928 cites W2894684271 @default.
- W3175679928 cites W2900648479 @default.
- W3175679928 cites W2902484351 @default.
- W3175679928 cites W2902706178 @default.
- W3175679928 cites W2948436219 @default.
- W3175679928 cites W2970731184 @default.
- W3175679928 cites W3016538158 @default.
- W3175679928 cites W3045571650 @default.
- W3175679928 cites W3092290441 @default.
- W3175679928 cites W3096662075 @default.
- W3175679928 doi "https://doi.org/10.1016/j.clml.2021.06.010" @default.
- W3175679928 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34274291" @default.
- W3175679928 hasPublicationYear "2021" @default.
- W3175679928 type Work @default.
- W3175679928 sameAs 3175679928 @default.
- W3175679928 citedByCount "8" @default.
- W3175679928 countsByYear W31756799282021 @default.
- W3175679928 countsByYear W31756799282022 @default.
- W3175679928 countsByYear W31756799282023 @default.
- W3175679928 crossrefType "journal-article" @default.
- W3175679928 hasAuthorship W3175679928A5022744383 @default.
- W3175679928 hasAuthorship W3175679928A5031658471 @default.
- W3175679928 hasAuthorship W3175679928A5031828516 @default.
- W3175679928 hasAuthorship W3175679928A5049387929 @default.
- W3175679928 hasAuthorship W3175679928A5073861459 @default.
- W3175679928 hasAuthorship W3175679928A5085732144 @default.
- W3175679928 hasConcept C126322002 @default.
- W3175679928 hasConcept C143998085 @default.
- W3175679928 hasConcept C2777607594 @default.
- W3175679928 hasConcept C2777609679 @default.
- W3175679928 hasConcept C2777938653 @default.
- W3175679928 hasConcept C2778461978 @default.
- W3175679928 hasConcept C2779675984 @default.
- W3175679928 hasConcept C2779878957 @default.
- W3175679928 hasConcept C71924100 @default.
- W3175679928 hasConceptScore W3175679928C126322002 @default.
- W3175679928 hasConceptScore W3175679928C143998085 @default.
- W3175679928 hasConceptScore W3175679928C2777607594 @default.
- W3175679928 hasConceptScore W3175679928C2777609679 @default.
- W3175679928 hasConceptScore W3175679928C2777938653 @default.
- W3175679928 hasConceptScore W3175679928C2778461978 @default.
- W3175679928 hasConceptScore W3175679928C2779675984 @default.
- W3175679928 hasConceptScore W3175679928C2779878957 @default.
- W3175679928 hasConceptScore W3175679928C71924100 @default.
- W3175679928 hasIssue "11" @default.
- W3175679928 hasLocation W31756799281 @default.
- W3175679928 hasLocation W31756799282 @default.
- W3175679928 hasOpenAccess W3175679928 @default.
- W3175679928 hasPrimaryLocation W31756799281 @default.
- W3175679928 hasRelatedWork W2204827588 @default.
- W3175679928 hasRelatedWork W2586959316 @default.
- W3175679928 hasRelatedWork W2754654824 @default.
- W3175679928 hasRelatedWork W2794302045 @default.
- W3175679928 hasRelatedWork W2894684271 @default.
- W3175679928 hasRelatedWork W2902590192 @default.
- W3175679928 hasRelatedWork W2946200248 @default.
- W3175679928 hasRelatedWork W4296793558 @default.
- W3175679928 hasRelatedWork W4308968203 @default.
- W3175679928 hasRelatedWork W4310356807 @default.
- W3175679928 hasVolume "21" @default.
- W3175679928 isParatext "false" @default.
- W3175679928 isRetracted "false" @default.
- W3175679928 magId "3175679928" @default.
- W3175679928 workType "article" @default.